Genetic variants in CYP11B1 influence the susceptibility to coronary heart disease

被引:5
|
作者
Huang, Xiaoli [1 ]
Cheng, Yimin [2 ]
Wang, Na [1 ]
机构
[1] Xian Hosp Tradit Chinese Med, Dept Cardiovascol, 69 Fengcheng Eighth Rd, Xian 710021, Peoples R China
[2] Hosp Xian Shiyou Univ, Dept Obstet & Gynecol, Xian 710065, Peoples R China
关键词
Coronary heart disease; Polymorphisms; Susceptibility; Gene; POLYMORPHISMS; RISK;
D O I
10.1186/s12920-022-01307-8
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Genetic factors are important risk factors to develop coronary heart disease (CHD). In this study, we mainly explored whether CYP11B1 mutations influence CHD risk among Chinese Han population. Methods Six variants were genotyped using Agena MassARRAY system from 509 CHD patients and 509 healthy controls. The correlations between CYP11B1 mutations and CHD risk were assessed using odds ratio (OR) and 95% confidence interval (95% CI) by logistic regression. The haplotype analysis and were ultifactor dimensionality reduction (MDR) were conducted. Results In the overall analysis, CYP11B1 polymorphisms were not correlated with CHD susceptibility. In the stratified analysis, we found that rs5283, rs6410, and rs4534 are significantly associated with susceptibility to CHD dependent on age and gender (p < 0.05). Moreover, we also observed that rs5283 and rs4534 could affect diabetes/hypertension risk among CHD patients (p < 0.05). In addition, the C(rs4736312)A(rs5017238)C(rs5301)G(rs5283)T(rs6410)C(rs4534) haplotype of CYP11B1 reduce the susceptibility to CHD (p < 0.05). Conclusions We found that rs4534, rs6410 and rs5283 in CYP11B1 gene influence the susceptibility to CHD, which depend on age and gender.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Molecular and Epigenetic Control of Aldosterone Synthase, CYP11B2 and 11-Hydroxylase, CYP11B1
    Takeda, Yoshimichi
    Demura, Masashi
    Kometani, Mitsuhiro
    Karashima, Shigehiro
    Yoneda, Takashi
    Takeda, Yoshiyu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
  • [32] Control of CYP11B2/CYP11B1 Expression Ratio and Consequences for the Zonation of the Adrenal Cortex
    Dringenberg, T.
    Schwitalla, M.
    Haase, M.
    Scherbaum, W. A.
    Willenberg, H. S.
    HORMONE AND METABOLIC RESEARCH, 2013, 45 (02) : 81 - 85
  • [33] Quantitative assessment of CYP11B1 and CYP11B2 expression in aldosterone-producing adenomas
    Fallo, F
    Pezzi, V
    Barzon, L
    Mulatero, P
    Veglio, F
    Sonino, N
    Mathis, JM
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2002, 147 (06) : 795 - 802
  • [34] Two intronic variants of CYP11B1 and CYP17A1 disrupt mRNA splicing and cause congenital adrenal hyperplasia (CAH)
    Dai, Weiqian
    Zhang, Xia
    Liu, Huili
    Sun, Yu
    Fan, Yanjie
    Yu, Yongguo
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2020, 33 (09): : 1225 - 1229
  • [35] MOLECULAR-CLONING AND CHARACTERIZATION OF THE OVINE CYP11B1 PROMOTER
    ANWAR, A
    JEYASEELAN, K
    COGHLAN, JP
    BIOCHEMISTRY AND MOLECULAR BIOLOGY INTERNATIONAL, 1994, 33 (06): : 1169 - 1178
  • [36] Inhibitors of 11β-Hydroxylase (CYP11B1) for Treating Diseases Related to Excess Cortisol
    Zhu, Weixing
    Chen, Zhuo
    Li, Qianbin
    Tan, Guishan
    Hu, Gaoyun
    CURRENT MEDICINAL CHEMISTRY, 2016, 23 (06) : 623 - 633
  • [37] Differential methylation of CYP11B1 in girls with high DHEAS levels
    Rodriguez, Fernando
    Ponce, Diana
    Miranda, Jose Patricio
    Santos, Jose Luis
    Cutler, Gordon B., Jr.
    Pereira, Ana
    Iniguez, German
    Mericq, Veronica
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 (SUPPL 2): : 48 - 48
  • [38] CYP11A1 stimulates the hydroxylase activity of CYP11B1 in mitochondria of recombinant yeast in vivo and in vitro
    Cauet, G
    Balbuena, D
    Achstetter, T
    Dumas, B
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (14): : 4054 - 4062
  • [39] Activity of the human CYP11B1 promoter in Y-1 cells
    Lenz, D
    Bernhardt, R
    FASEB JOURNAL, 1997, 11 (09): : A799 - A799
  • [40] A RARE CASE OF GENE CYP11B1 DEFICIENCY CAUSING HYPERALDOSTERONISM
    Kayes, M.
    Tarafdar, S.
    NEPHROLOGY, 2017, 22 : 38 - 39